LOPACUT

This brand name is authorized in Estonia, Finland, Germany, Lithuania, Poland.

Active ingredients

The drug LOPACUT contains one active pharmaceutical ingredient (API):

1	Loperamide UNII 77TI35393C - LOPERAMIDE HYDROCHLORIDE
	By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.
	Read more about Loperamide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07DA03	Loperamide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	03031544
EE	Ravimiamet	1438039, 1503571
FI	Lääkealan turvallisuus- ja kehittämiskeskus	441794
LT	Valstybinė vaistų kontrolės tarnyba	1050648, 1058218
PL	Rejestru Produktów Leczniczych	100252827